The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical ...(tual performance or achievements tobe ma...),Health
tual performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statement. Factors that impact such forward-looking statements include, among others, changes in worldwide general economic conditions, changes in interest rates, government regulations, and worldwide competition.
CONTACT:
Gerard M. Gleeson Carl Hymans
Vice President, CFO G.S. Schwartz & Co.
(215) 345-0919 (212) 725-4500
(Tables Follow)
Consolidated Statements of Operations (Unaudited)
The following represents condensed financial data (in thousands) except per share data:
Three-Months Three-Months Nine-Months Nine-Months
Ended Ended Ended Ended
September September September September
30, 2008 30, 2007 30, 2008 30, 2007
($) ($) ($) ($)
Net Sales 6,354 9,132 13,728 17,499
Gross profit 4,082 5,980 8,550 10,913
Sales & marketing expenses 652 865 3,450 3,911
Administrative expenses 1,661 1,868 6,200 6,449
Research & development 955 2,018 3,630 4,792
Income taxes (benefit) - - - -
Income (Loss) from:
Continuing operations 879 1,384 (4,445) (3,674)
Discontinued operations - (55) 876 (445)
Net Income (Loss) 879 1,329 (3,569) (4,119)
Diluted income (loss) per share:
'/>"/>
| SOURCE The Quigley Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. The Quigley Corporation Announces Sale of Its Health and Wellness Segment
2. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
3. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
4. The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director
5. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
6. Brooke Franchise Corporation Announces Selected July Results
7. MedThink Communications Retained by NanoBio Corporation
8. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
9. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
10. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
11. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |